Compumedics Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

David Burton

Directeur général

AU$253.4k

Rémunération totale

Pourcentage du salaire du PDG	90.1%
Durée du mandat du directeur général	37.8yrs
Propriété du PDG	53.4%
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	7.9yrs

Mises à jour récentes de la gestion

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

Jun 17

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14

Is Compumedics (ASX:CMP) Using Debt Sensibly?

May 02

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Dec 08

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Aug 09

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Jun 10

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

May 06

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Feb 25

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 01

Analyse de la rémunération des PDG

Comment la rémunération de David Burton a-t-elle évolué par rapport aux bénéfices de Compumedics?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	AU$253k	AU$228k	-AU$338k
Mar 31 2024	n/a	n/a	AU$447k
Dec 31 2023	n/a	n/a	AU$1m
Sep 30 2023	n/a	n/a	-AU$2m
Jun 30 2023	AU$252k	AU$228k	-AU$6m
Mar 31 2023	n/a	n/a	-AU$6m
Dec 31 2022	n/a	n/a	-AU$6m
Sep 30 2022	n/a	n/a	-AU$2m
Jun 30 2022	AU$251k	AU$228k	AU$1m
Mar 31 2022	n/a	n/a	AU$663k
Dec 31 2021	n/a	n/a	-AU$31k
Sep 30 2021	n/a	n/a	AU$484k
Jun 30 2021	AU$244k	AU$223k	AU$998k
Mar 31 2021	n/a	n/a	-AU$2m
Dec 31 2020	n/a	n/a	-AU$5m
Sep 30 2020	n/a	n/a	-AU$5m
Jun 30 2020	AU$237k	AU$217k	-AU$6m
Mar 31 2020	n/a	n/a	-AU$1m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$4m
Jun 30 2019	AU$250k	AU$228k	AU$4m
Mar 31 2019	n/a	n/a	AU$3m
Dec 31 2018	n/a	n/a	AU$3m
Sep 30 2018	n/a	n/a	AU$3m
Jun 30 2018	AU$250k	AU$228k	AU$3m

Rémunération vs marché: La rémunération totale de David ($USD 164.67K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Australian ($USD 297.98K ).

Rémunération et revenus: La rémunération de David a augmenté alors que l'entreprise n'est pas rentable.

PDG

David Burton (65 yo)

37.8yrs

Titularisation

AU$253,391

Compensation

Dr. David Burton, Ph.D. founded Compumedics Ltd. in 1987 and serves as its Executive Chairman and Chief Executive Officer. Dr. Burton serves as Executive Chairman and Chief Executive Officer of Compumedics...

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
David Burton	Founder	no data	AU$253.39k	53.35% A$ 27.9m
David Lawson	CFO, Company Secretary & Executive Director	11.1yrs	AU$389.91k	1.89% A$ 989.2k
Rodney North	Non-Executive Director	2.1yrs	AU$30.00k	0.0011% A$ 570.9
Patrice Bourgin	Member of Medical Advisory Board	7.9yrs	pas de données	pas de données
John Ebersole	Member of Medical Advisory Board	7.9yrs	pas de données	pas de données
Ian Colrain	Member of Medical Advisory Board	7.9yrs	pas de données	pas de données

7.9yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Les membres du conseil d'administration de CMP sont considérés comme expérimentés (ancienneté moyenne 7.9 ans).

Compumedics Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Compumedics Limited, Annual General Meeting, Oct 31, 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in FY 2023)

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.035 loss in FY 2023)

New minor risk - Shareholder dilution

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

New minor risk - Share price stability

Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)

New major risk - Share price stability

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Full year 2023 earnings released: AU$0.035 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited, Annual General Meeting, Oct 31, 2023

Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited Provides Revenue Guidance for the Year 2023

Is Compumedics (ASX:CMP) A Risky Investment?

Compumedics Limited Re-Affirms Earnings Guidance for the Fiscal Year 2023

First half 2023 earnings released: AU$0.041 loss per share (vs AU$0.002 profit in 1H 2022)

Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company

Compumedics Limited Provides Revenue Guidance for the First Half of Fiscal Year 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited Provides Revenue Guidance for the Fiscal Year 2023

Is Compumedics (ASX:CMP) Using Debt Sensibly?

No independent directors

Tucson Dunn Retires as Director of Compumedics Limited, Effective 31 March, 2022

First half 2022 earnings: EPS and revenues miss analyst expectations

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

New 90-day low: AU$0.41

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

First half 2021 earnings released: EPS AU$0.007 (vs AU$0.001 in 1H 2020)

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Price target lowered to AU$1.00

Compumedics Limited Announces Not to Provide Guidance for the Fiscal Year 2021

Compumedics Limited Announces That Sales Forecasts Will Remain Problematic Due to COVID-19 Pandemic

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Membres du conseil d'administration

Durée moyenne de l'emploi